| Ytd | -41.83% | |
| 1y | -8.14% |
| Open | 4.09 | Prev Close | 4.13 | Low | 3.93 | High | 4.32 | Mkt Cap | 249.99M |
| Vol | 198.96K | Avg Vol | 275.38K | EPS | -1.22 | P/E | N/A | Forward P/E | -3.50 |
| Beta | 0.50 | Short Ratio | 2.38 | Inst. Own | 17.27% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 4.88 | 200-d Avg | 4.61 | 1yr Est | 11.64 |
TriSalus Life Sciences (NASDAQ: TLSI - Get Free Report) and Innovative Eyewear (NASDAQ: LUCY - Get F
U.S. stocks fell Wednesday, led by a 1.1% Nasdaq drop. Cintas beat estimates and raised guidance; oi
The U.S. Food and Drug Administration (FDA) on Wednesday granted 510(k) clearance for TriSalus Life
TriSalus Life Sciences secured FDA clearance for its TriNav Advance device, but shares face critical
U.S. stocks were lower, with the Nasdaq Composite falling over 100 points on Wednesday.
U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securit
Analysts raised targets for Meta, Microsoft, Valero and others; Microsoft upgraded to Buy, while KB
IONQ: 14% | IonQ shares are trading higher after the company announced that researchers demonstrated
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains TriSalus Life Sciences (NASDAQ:T
Worthington Enterprises surged 15.9% premarket after beating Q1 EPS and sales estimates; Wheeler REI
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 32.2% to $45.56 during Tuesday's af
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an
Analysts initiate coverage: Buy ratings for Robinhood ($170), TriSalus ($11), Kodiak AI ($8); Underp
HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on TriSalus Life Scienc
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences to Participate in the H.C. Wainwright &
TriSalus Life Sciences NASDAQ: TLSI outlined its commercial expansion, product pipeline and clinical
TriSalus Life Sciences NASDAQ: TLSI reported second-quarter revenue of $11.4 million, up 1.7% from $
TriSalus Life Sciences, Inc. (TLSI) Q2 2026 Earnings Call Transcript
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology co
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an
NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
LOS ANGELES, June 17, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights li
NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
LOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litiga
NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights li
TriSalus Life Sciences, Inc. (Nasdaq: TLSI), an oncology company integrating novel delivery technolo
US stocks mixed, Nasdaq up 200 points. Dow down 0.43%, Nasdaq up 0.79%, S&P 500 up 0.27%. Commun
US stocks mixed as Dow drops over 200 points on opening. Nasdaq up 0.13%, S&P 500 down 0.13%. Te
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quar
Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $
On Thursday, 283 companies set new 52-week lows.
On Tuesday, 164 companies achieved new lows for the year.
U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Frid
U.S. stocks traded down this morning with the Nasdaq Composite falling more than 101 points on Frida